Syrris’ Free Flow Chemistry Workshops in High Demand
News Feb 06, 2015
Syrris enjoyed another successful global series of flow chemistry seminars in 2014. These free events, which combine theoretical discussion with hands-on sessions, enabled chemists to develop their understanding of the many and varied benefits of flow chemistry.
Flow chemistry has emerged as an exciting technology for research and development chemists over the last decade, enabling a wide variety of chemical reactions to be quickly and easily performed, as well as allowing integration of synthesis, work-up and analysis in a single workflow.
As a market leader in the sector, Syrris has been offering free flow chemistry seminars for three years, and the 2014 series - which included events in Denmark, Switzerland, USA, UK, Germany, Belgium, France, Mexico, Sweden and Japan - proved more popular than ever.
Delegates from a wide range of backgrounds took advantage of the company’s extensive knowledge and experience to learn how to perform reactions that are not possible using traditional techniques, seeing for themselves how flow chemistry can provide safer, faster and cleaner reactions.
Dr Laure Théveau, a postdoctoral fellow at the KTH Royal Institute of Technology, Sweden, attended the Stockholm workshop and commented: “Flow chemistry is becoming increasingly common in scientific literature, and I was keen to learn more about the technique. Both the theoretical and practical sessions were very complementary, combining clear explanations and an overview of the technique with detailed technical information and advice on troubleshooting. I would certainly recommend the workshops to anyone looking at implementing flow chemistry methods in their laboratory.”
Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes SynthesisNews
TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.READ MORE
Innovative ALS Therapy Startup Wins Golden Ticket Funding From AmgenNews
Amgen and LabCentral have announced that Kernal Biologics Inc. and QurAlis have won the Amgen Golden Ticket at LabCentral.READ MORE